Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Tianjin

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

7

Recruiting now

10

Active studies

Recruiting Phase 3

A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso · started 2025-08-14

📍 Beijing · Fuzhou · Shijiazhuang · Harbin · Shanghai · Tianjin

NCT07023315 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd · started 2025-05-14

📍 Wuxi · Tianjin

NCT06970119 on ClinicalTrials.gov ↗

Recruiting Phase 2

Qinqiao Yan Shu Granules for the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome) Phase II Clinical Trial

Acute Pharyngitis
Jianmin Pharmaceutical Group Co., LTD. · started 2025-03-26

📍 Harbin · Changsha · Changchun · Jinan · Luzhou · Tianjin

NCT06932328 on ClinicalTrials.gov ↗

Recruiting

Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. · started 2024-12-15

📍 Beijing · Tianjin · Wuhan · Zhengzhou

NCT07028970 on ClinicalTrials.gov ↗

Recruiting

Long-term Follow-up Study of BRL-101 for TDT

Thalassemia, Beta
Bioray Laboratories · started 2024-12-08

📍 Guangzhou · Shenzhen · Nanning · Changsha · Tianjin · Guangxi

NCT06298630 on ClinicalTrials.gov ↗

Recruiting

ALI & Pulmonary HA Deposition After SAH

Subarachnoid Haemorrhage (SAH)
Tianjin Medical University · started 2024-12-01

📍 Tianjin

NCT06628531 on ClinicalTrials.gov ↗

Starting soon Phase 1

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma, B-cell
Sinocelltech Ltd. · started 2024-04

📍 Beijing · Zhengzhou · Tianjin

NCT06318884 on ClinicalTrials.gov ↗

Recruiting Phase 2

Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia

Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China · started 2023-12-03

📍 Hefei · Zhoukou · Tianjin

NCT06224257 on ClinicalTrials.gov ↗

Active Phase 2

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Solid Tumors
Hoffmann-La Roche · started 2021-01-18

📍 Beijing · Chengdu · Shanghai · Tianjin · Xi'an

NCT04589845 on ClinicalTrials.gov ↗

Active Phase 2

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche · started 2020-11-27

📍 Changchun · Guangzhou · Linyi · Nanchang · Shanghai · Tianjin

NCT04576455 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2

Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/tianjin (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.